Rubius Therapeutics Inc (OTC Pink - Limited Information:RUBY)
| 0.0204 Delayed Data As of May 26 |  +0.0031 / +17.92%Today’s Change | 0.01 Today|||52-Week Range 1.57 | -88.34% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Assets | Cash | 6.8M | 104.3M | 307.7M | -- | |
| Short Term Investment Cash | 5.5M | 97.5M | 204.8M | -- | ||
| Cash & Short Term Investments | 6.8M | 104.3M | 404.7M | -- | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | -- | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | -- | -- |
| Current Assets | Other Current Assets | 53.0K | 700.0K | 9.7M | -- | |
| Current Assets | 6.9M | 105.0M | 414.4M | -- | ||
| Total Assets | Property, Plant and Equipment - Gross | 1.0M | 3.0M | 64.6M | -- | |
| Depreciation | -137.0K | -584.0K | -1.8M | -- | ||
| Other Assets | 0.00 | 0.00 | 168.0K | -- | ||
| Total Assets | 8.0M | 107.7M | 479.1M | -- | ||
| Liabilities | Accounts Payable | 1.2M | 2.0M | 7.9M | -- | |
| Short Term Debt | 933.0K | 2.1M | 4.5M | -- | ||
| Accrued Expenses | 237.0K | 1.2M | 2.3M | -- | ||
| Other Current Liabilities | 308.0K | 1.4M | 4.2M | -- | ||
| Other Liabilities | 2.9M | 7.2M | 20.0M | -- | ||
| Total Liabilities | Long Term Debt | 3.0M | 3.3M | 65.8M | -- | |
| Other Liabilities | 136.0K | 158.0K | 143.0K | -- | ||
| Total Liabilities | 6.0M | 11.5M | 85.9M | -- | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | -- | -- |
| Preferred Stock | 19.1M | 139.8M | 0.00 | -- | ||
| Common Equity | -17.1M | -43.7M | 393.0M | -- | ||
| Total Shareholder Equity | 1.9M | 96.1M | 393.0M | -- | ||
| Share Information | Common Shares Outstanding | 78.9M | 78.9M | 79.2M | -- | |
| Addtl. Info. | No data currently available for this section. | |||||
